Concepedia

Kevin Budding

KB

Statistics

Publications

9

Citations

248

H-Index

9

Active since

2014

Affiliations

University Medical Center Utrecht(Current)

St. Antonius Ziekenhuis

Utrecht University

Argenx (Belgium)

Ablynx (Belgium)

Kevin Budding is an author at University Medical Center Utrecht specializing in immunology, life sciences, and complement system.

ORCID

Publications per year

2014–2022

9

Publications

9

ARGX-117, a therapeutic complement inhibiting antibody targeting C2

Inge Van de Walle, Karen Silence, Kevin Budding et al. · Journal of Allergy and Clinical Immunology · 2020 · 52 citations · Full text

, , +17

A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation

Kevin Budding, E.A. van de Graaf, Tineke Kardol‐Hoefnagel et al. · American Journal of Transplantation · 2015 · 34 citations · Full text

, , +17

Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation

Kevin Budding, E.A. van de Graaf, Tineke Kardol‐Hoefnagel et al. · Scientific Reports · 2016 · 34 citations · Full text

, , +17

Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis

Kevin Budding, E.A. van de Graaf, Tineke Hoefnagel et al. · Journal of Cystic Fibrosis · 2014 · 29 citations

, , +10

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Mitchell Evers, Marjolein C. Stip, Kaylee M. Keller et al. · Journal for ImmunoTherapy of Cancer · 2021 · 27 citations · Full text

, , +15

1–5 of 9